RP
Regeneron Pharmaceuticals Portfolio holdings
AUM
$1.49B
This Quarter Return
+13.83%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.23B
AUM Growth
+$140M
(+13%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alnylam Pharmaceuticals
ALNY
$61.1B
| $1.2B | 97.23% |
4,444,445
| – | – |
|
2
Intellia Therapeutics
NTLA
$1.23B
| $26.3M | 2.13% |
3,702,995
| – | – |
|
|
TSVT
3
DELISTED
2seventy bio
TSVT
| $6.2M | 0.5% |
1,254,827
| – | – |
|
4
Adverum Biotechnologies
ADVM
$63.4M
| $791K | 0.06% |
180,909
| – | – |
|
5
Adicet Bio
ACET
$67.5M
| $731K | 0.06% |
968,183
| – | – |
|
|
BLUE
6
DELISTED
bluebird bio
BLUE
| $102K | 0.01% |
21,000
| – | – |
|